The correct name for bupropion extended-release tablets is bupropion hydrochloride extended-release tablets. It is the first non-nicotine replacement therapy smoking cessation medication for assisting smoking cessation, which is effective, non-dependent and non-addictive. Patients can also ask their doctors to choose a reasonable method of treatment according to their situation. Some adverse reactions may occur after taking bupropion hydrochloride extended-release tablets such as: neck pain, allergic reaction, hot flashes, high blood pressure, dry mouth, increased appetite, lack of appetite, arthralgia, myalgia, insomnia, dizziness, panic, drowsiness, abnormal thinking, bronchitis, itching, dry skin, rubeola, and abnormal taste. This product is contraindicated in patients with epileptic seizures, patients with bulimia or anorexia, patients using other drugs containing bupropion ingredients while taking the drug, patients who are allergic to bupropion or similar ingredients, and patients who have abruptly stopped drinking or discontinued sedation. This product should not be combined with monoamine oxidase inhibitors or drugs containing bupropion hydrochloride. It should be used with caution in patients with heart disease, in patients with liver damage, and should not be used by pregnant women. This product may cause insomnia, avoid taking it before bedtime. If you need to use Bupropion Hydrochloride Extended-Release Tablets, please consult a professional doctor, follow the doctor’s instructions, and use medication reasonably.